Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving the Diagnosis of Common Variable Immune Deficiency by Analysis of Innate and Adaptive Signaling Pathways

NCT03335605 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT03335605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03335605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving the Diagnosis of Common Variable Immune Deficiency by Analysis of Innate and Adaptive Signaling Pathways
Lead sponsor
University of California, Los Angeles
Phase
Observational
Overall status
Completed
Start date
May 1, 2019
Completion date
June 1, 2022
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cvi - common variable immunodeficiency